These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15087777)

  • 1. Lymphedema associated with sirolimus in renal transplant recipients.
    Aboujaoude W; Milgrom ML; Govani MV
    Transplantation; 2004 Apr; 77(7):1094-6. PubMed ID: 15087777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-sided limb lymphedema in a liver transplant recipient receiving sirolimus.
    van Onna M; Geerts A; Van Vlierberghe H; Berrevoet F; de Hemptinne B; Troisi R; Colle I
    Acta Gastroenterol Belg; 2007; 70(4):357-9. PubMed ID: 18330092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe limb lymphedema in sirolimus-treated patients.
    Romagnoli J; Citterio F; Nanni G; Tondolo V; Castagneto M
    Transplant Proc; 2005 Mar; 37(2):834-6. PubMed ID: 15848548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphedema in renal transplant recipients under immunosuppression with sirolimus: presentation of 2 cases.
    Baliu C; Esforzado N; Campistol JM; Mascaró JM
    JAMA Dermatol; 2014 Sep; 150(9):1023-4. PubMed ID: 24898278
    [No Abstract]   [Full Text] [Related]  

  • 5. Generalized lymphedema in a sirolimus-treated renal transplant patient.
    De Bartolomeis C; Collini A; Rumberger B; Barni R; Ruggieri G; Bernini M; Carmellini M
    Clin Transplant; 2008; 22(2):254-7. PubMed ID: 18339149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sirolimus-induced lymphedema in a kidney-transplant recipient: Partial recovery after changeover to tacrolimus].
    Al Gain M; Crickx B; Bejar C; Chen L; Azeroual L; Marinho E; Descamps V
    Ann Dermatol Venereol; 2015 May; 142(5):350-5. PubMed ID: 25683011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphedema of the Transplanted Kidney and Abdominal Wall with Ipsilateral Pleural Effusion Following Kidney Biopsy in a Patient Treated with Sirolimus: A Case Report and Review of the Literature.
    Rashid-Farokhi F; Afshar H
    Am J Case Rep; 2017 Dec; 18():1370-1376. PubMed ID: 29269724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
    Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
    Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-volume sirolimus-induced upper limb lymphedema after renal transplantation ipsilateral to the arteriovenous fistula.
    Vignes S; Brunet M; Blanchard M; Smail A; Arrault M
    Lymphat Res Biol; 2014 Sep; 12(3):185-8. PubMed ID: 25162929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphedema in patients treated with sirolimus: 15 cases].
    Fourgeaud C; Simon L; Benoughidane B; Vignes S
    Rev Med Interne; 2019 Mar; 40(3):151-157. PubMed ID: 29752013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphedema: an unusual complication of sirolimus therapy.
    Al-Otaibi T; Ahamed N; Nampoory MR; Al-Kandari N; Nair P; Hallm MA; Said T; Samhan M; Al-Mousawi M
    Transplant Proc; 2007 May; 39(4):1207-10. PubMed ID: 17524934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus-induced lymphedema in a renal transplant recipient: a case report.
    Ersoy A; Koca N
    Exp Clin Transplant; 2012 Jun; 10(3):296-8. PubMed ID: 22631070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucocutaneous disorders in renal transplant recipients receiving sirolimus-based immunosuppressive therapy: a prospective, case-control study.
    Özcan D; Seçkin D; Ada S; Haberal M
    Clin Transplant; 2013; 27(5):742-8. PubMed ID: 23991694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria in transplant patients associated with sirolimus.
    Franco AF; Martini D; Abensur H; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):449-52. PubMed ID: 17362756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-induced inflammatory lymphoedema of the breast resolved after switching to cyclosporine.
    Tauveron V; Bourdu S; Barbet C; de Muret A; Burgot M; Desmidt F; Vaillant L; Machet L
    Acta Derm Venereol; 2015 Jan; 95(1):108-9. PubMed ID: 24807192
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for wound healing complications in sirolimus-treated renal transplant recipients.
    Grim SA; Slover CM; Sankary H; Oberholzer J; Benedetti E; Clark NM
    Transplant Proc; 2006 Dec; 38(10):3520-3. PubMed ID: 17175320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria after conversion to sirolimus in renal transplant recipients.
    Sahin GM; Sahin S; Kantarci G; Ergin H
    Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management.
    Hong JC; Kahan BD
    Transplantation; 2000 May; 69(10):2085-90. PubMed ID: 10852601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
    Friend P; Russ G; Oberbauer R; Murgia MG; Tufveson G; Chapman J; Blancho G; Mota A; Grandaliano G; Campistol JM; Brault Y; Burke JT;
    Transpl Int; 2007 Sep; 20(9):754-60. PubMed ID: 17565578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.